Skip to main content
. 2018 Dec;24(12):10.18553/jmcp.2018.24.12.1230. doi: 10.18553/jmcp.2018.24.12.1230
Brand Name Generic Name FDA Approval Exclusion Reason
Qutenza Capsaicin 11/16/2009 Previously approved
Lumozyme Glucosidase alfa2 5/24/2010 Previously approved
Ammonia N13 Ammonia 8/23/2007 Imaging agent
Lexiscan Regadenoson 4/10/2008 Imaging agent
Eovist Gadoxetate disodium 7/3/2008 Imaging agent
Adreview Iobenguane 9/19/2008 Imaging agent
Ablavar Gadofosveset trisodium 12/22/2008 Imaging agent
Datscan Ioflupane i-123 1/14/2011 Imaging agent
Gadavist Gadobutrol 3/14/2011 Imaging agent
Amyvid Florbetapir F 18 4/6/2012 Imaging agent
Choline C11 Choline C11 injection 9/12/2012 Imaging agent
Surfaxin Lucinactant 3/6/2012 Pediatric indication
Anthelios SX Avobenzone; ecamsule; octocrylene 7/21/2006 Over the counter
Belviq Lorcaserin hydrochloride 6/27/2012 Weight loss medication
Mircera Methoxy polyethylene glycol-epoetin beta 11/14/2007 NDC unmatched in database
Stendra Avanafil 4/27/2012 NDC unmatched in database
Granix Tbo-filgrastim 8/29/2012 NDC unmatched in database
Fycompa Perampanel 10/22/2012 NDC unmatched in database
------------- Raxibacumab 12/14/2012 NDC unmatched in database
Neupro Rotigotine 5/9/2007 Drug withdrawn
Iclusig Ponatinib 12/14/2012 Drug withdrawn
Omontys Peginesatide acetate 3/27/2012 Drug withdrawn

FDA = U.S. Food and Drug Administration; NDC = National Drug Code.